-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II

Symposia: Chronic Lymphocytic Leukemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Roberta Santos Azevedo, MD1,2*, Francesca Morelli, MD3,4*, Kiyomi Mashima, MD, PhD1,5, Rayan Fardoun1*, Svitlana Tyekucheva, PhD6,7*, Stacey M Fernandes, BS1*, Samantha J. Shupe, BS1*, Marissa Terra1*, Anisha Patel1*, Joseph Yu1* and Jennifer R. Brown, MD, PhD1,5

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Hospital Nove de Julho, São Paulo, Brazil
3Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
4Department of Hematology, University of Florence, Florence, Italy
5Department of Medicine, Harvard Medical School, Boston, MA
6Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
7Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA

Nitin Jain, MD1, Philip Thompson, MBBS1, Akhil Jain, MD1*, Jan A. Burger, MD, PhD 2, Alessandra Ferrajoli, MD1, Jayastu Senapati, MD, MBBS, DM1, Koichi Takahashi, MD, PhD1, Mahesh Swaminathan, MD1, Zeev Estrov, MD1, Gautam Borthakur, MD1, Prithviraj Bose, MD1, Tapan M. Kadia, MD1, Naveen Pemmaraju, MD1, Koji Sasaki, MD1, Divyam Bansal1*, Marina Y. Konopleva1, Elias Jabbour1, Naveen Garg, MD3*, Xuemei Wang, MS4*, Rashmi Kanagal-Shamanna, MD5, Keyur P. Patel, MBBS, PhD6, Wei Wang6*, Sa A. Wang6, Jeffrey L. Jorgensen, MD6, Wanda Lopez, RN1*, Ana Ayala, RN1*, William Plunkett, PhD7, Varsha Gandhi, PhD7, Hagop M. Kantarjian, MD1, Susan M. O'Brien8, Michael J. Keating, MBBS1 and William G. Wierda, MD, PhD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, MD Anderson Cancer Center, Houston, TX
3Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX
6Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
8Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA

Anne-Sophie Michallet, MD, PhD1*, Anne Quinquenel, MD, PhD2*, Remi Letestu3*, Tavernier Magali4*, Stéphane Morisset5*, Therese Aurran6*, Kamel Laribi7*, Florence Cymbalista, MD, PhD8*, Vincent Levy, MD, PhD9*, Laurence Simon10*, Damien Roos Weil, MD, PhD11*, Veronique Leblond, MD12*, Marie Sarah Dilhuydy, MD13*, Cecile Tomowiak14*, Caroline Dartigeas15*, Romain Guieze, MD, PhD16*, Olivier Tournilhac17*, Emmanuelle Ferrant, MD18*, Sophie De Guibert19*, Pierre Feugier20*, Fatiha Merabet21*, Stéphane Lepretre22*, Philippe Carassou23*, Julie Gay24*, Benedicte Hivert25*, Luc Matthieu Fornecker, MD, PhD26*, Jehan Dupuis27*, Lysiane Molina, MD28*, Bruno Villemagne29*, Guillaume Cartron, MD, Ph-D30*, Bernard Drenou, MD31*, Béatrice Mahé32*, Omar Benbrahim33*, Xavier Cahu34*, Christelle Portois35*, Loic Ysebaert, MD, PhD36*, Florence Nguyen Khac37*, Valerie Rouillé38* and Alain Jacques Delmer, MD39*

1Centre Leon Berard, Lyon, France
2Hematology department, Robert Debré University Hospital, Reims, France
3APHP, Avicennes Hospital, Bobigny, FM, FRA
4APHP, la pitié salpetriere, Paris, FRANCE, FRA
5Hospices Civils De Lyon, Chazey-sur-Ain, FRA
6Institut Paoli-Calmettes, Marseille, FRA
7Hematology Department, Le Mans Hospital, Le Mans, France
8Hopital Avicenne, Bobigny, FRA
9Hôpital Avicenne, AP-HP, BOBIGNY, France
10hospital Corbeil essonnes, Corbeil-Essonnes, FRA
11Clinical Hematology, APHP, La Pitié Salpétriere, Sorbonne Universite, Paris, FRA
12APHP, La pitié salpétriere, Paris, FRA
13CHU Bordeaux, PESSAC, FRA
14Centre Hospitalier Universitaire de Poitiers, Poitiers, France
15CHU Bretonneau, Tours, FRA
16CHU Estaing, Clermont Ferrand, FRA
17CHU clermont ferrand, Clermont ferrand, France
18CHU Lyon Sud, Pierre Benite, FRA
19Centre Hospitalier Pontchaillou, Rennes, FRA
20Henri Poincaré University, Vandoeuvre Les Nancy, FRA
21andre mignot hospital, LE CHESNAY, FRA
22centre henri becquerel, Rouen, FRA
23chu metz thionville, Ars Laquenexy, FRA
24Hospital St Antoine, Paris, FRA
25GHICL, Lille, FRA
26Institut de cancérologie Strasbourg Europe, Strasbourg, France
27APHP, Creteil, Creteil, FRA
28CHU grenoble, grenoble, France
29CH la roche sur yon, La Roche Sur Yon, FRA
30Dept. Biological Hematology, Montpellier University Hospital Center, Montpellier, FRA
31HôPital Emile Muller, Mulhouse Cedex 1, FRA
32CHU nantes, Nantes, FRA
33HOPITAL LA SOURCE, La Source, FRA
34hospital cesson sevigne, cesson sevigne, France
35CHU SAINT ETIENNE, Saint Etienne, FRA
36Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
37Hôpital Pitié-Salpêtrière, Service d'Hématologie, Paris Cedex 13, France
38CHU montpellier, montpellier, France
39Hôpital Robert Debré CHU de Reims, Reims Cedex, -, FRA

Lindsey E. Roeker, MD1, Jennifer A. Woyach, MD2, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc3, Catherine C Coombs, MD4*, Nirav N. Shah, MD5, William G. Wierda, MD, PhD6, Manish Patel, MD7*, Donald E. Tsai, MD, PhD8*, Binoj Nair, PhD8*, Chunxiao Wang, Ph.D.9*, Xiang Zhao8*, Narasimha Marella, Ph.D.8*, Caleb Ho, M.D.8, Samuel McNeely, PhD9* and Jennifer R. Brown, MD, PhD10

1Memorial Sloan Kettering Cancer Center, New York, NY
2The Ohio State University Comprehensive Cancer Center, Columbus, OH
3Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
4University of California Irvine Health, Orange, CA
5Medical College of Wisconsin, Milwaukee, WI
6MD Anderson Cancer Center, Houston, TX
7Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL
8Loxo@Lilly, Indianapolis, IN
9Eli Lilly and Company, Indianapolis, IN
10Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

Mariia Mikhaleva, MD1,2*, Svitlana Tyekucheva, PhD3,4*, Kiyomi Mashima, MD, PhD1,5, Stacey M Fernandes, BS1*, Matthew S. Davids, MD, MMSc1,5 and Jennifer R. Brown, MD, PhD1,5

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Russian Research Institute of Hematology and Transfusiology, Saint-Petersburg, Russia
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA
5Department of Medicine, Harvard Medical School, Boston, MA

Paul J. Hampel, MD1, Kari G. Rabe, MS2*, Yucai Wang, MD, PhD3, Steven R Hwang, MD, BS3, Saad S. Kenderian, MD3, Eli Muchtar, MD2, Jose F. Leis, MD, PhD4, Amber Koehler, PA-C5*, Mazie Tsang, MD6, Ricardo Parrondo, MD7, Rachel Bubik, PharmD2*, Susan Marie Schwager2*, Curtis A. Hanson, MD8*, Esteban Braggio, PhD9, Susan L. Slager, PhD3, Min Shi, MD, PhD2*, Daniel L. Van Dyke, PhD2, Timothy G. Call, MD3, Neil E. Kay, MD3,10, Wei Ding, MD, PhD3 and Sameer A. Parikh, MD1

1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, AZ
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester
6Mayo Clinic, Phoenix, AZ
7Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
8Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
9Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
10Department of Immunology, Mayo Clinic, Rochester, MN

Kerry A Rogers, MD1, Qiuhong Zhao, MS1*, Seema A Bhat, MD1, John C. Byrd, MD2, Cara Grantier, CNP3*, Michael R. Grever, MD1, Corinne Hoffman, MS, NP3*, Adam S Kittai, MD1, Gerard Lozanski, MD4*, Margaret S. Lucas, PA-C1*, Lindsey Rike3*, Shanmugapriya Thangavadivel, PhD1*, William E. Carson III, MD, PhD5* and Jennifer A. Woyach, MD1

1Division of Hematology, The Ohio State University, Columbus, OH
2Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
3Comprehensive Cancer Center, The Ohio State University, Columbus, OH
4Department of Pathology, The Ohio State University, Columbus, OH
5Department of Surgery, The Ohio State University, Columbus

Loic Ysebaert, MD, PhD1*, Emmanuelle Ferrant, MD2*, Marie Sarah Dilhuydy, MD3*, Anne-Sophie Michallet, MD, PhD4*, Luca Inchiappa5*, Romain Guieze, MD, PhD6*, Emmanuelle Tchernonog7*, Ana Cavillon8*, Marie Christine Bene9* and Luc-Matthieu Fornecker, MD, PhD10*

1Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
2Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d’Hématologie Clinique, Pierre-Bénite, France
3CHU Bordeaux, PESSAC, FRA
4Centre Leon Berard, Lyon, France
5Hematology Department, Institut Paoli-Calmettes, MARSEILLE CEDEX 09, France
6CHU Estaing, Clermont Ferrand, FRA
7Hematology Department, CHU Montpellier, Montpellier Cedex 5, France
8Statistics Department, Institut Universitaire du Cancer de Toulouse-Oncopôle, Toulouse, France
9Hopital Hotel Dieu & Hme, Nantes, France
10Hematology Department, Institut De Cancérologie Strasbourg Europe, Strasbourg, France

Andrew H. Lipsky, MD1, Brian T. Hill, MD2, Allison Winter, MD3, Spencer Henick Bachow, MD4, Aaron D. Viny, MD, MS1, Todd L. Rosenblat, MD, MS1*, Joseph Jurcic, MD1 and Nicole Lamanna, MD5

1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
2Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, OH
3Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Eugene M. & Christine E. Lynn Cancer Institute, Boca Raton Regional Hospital, Boca Raton, FL
5Herbert Irving Comprehensive Cancer Center, New York-Presbyterian/Columbia University Medical Center, New York, NY

Andrea Visentin, MD, PhD1*, Enrico Gaffo, PhD2*, Moritz Furstenau, MD3*, Jennifer A. Woyach, MD4, Panagiotis Baliakas, MD5*, Kerry A Rogers, MD6, Cecelia Miller, PhD4*, Claudia Haferlach, MD7, Karla Plevova8*, David Graham Oscier, MD, PhD9, Zadie Davis10*, Florence Nguyen Khac11*, Eleonora Roncaglia, MS12*, Gian Matteo Rigolin, MD13*, Anastasia Athanasiadou, MD14*, Fanny Baran-Marszak, MD, PhD15*, Alberto Valiente16*, Maria Jose Terol, MD17*, Pau Abrisqueta, MD, PhD18, Blanca Espinet, PhD19*, Anna Puiggros, PhD19*, Annalisa Martines20*, Laura Bonaldi20*, Francesca Romana Mauro21*, Lydia Scarfo, MD22, Thomas Chatzikonstantinou23*, Eugen Tausch, MD24*, Karl Anton Kreuzer3*, Arnon P. Kater, MD, PhD25, Francesc Bosch, MD, PhD26, Michael Doubek, MD8*, Panayiotis Panayiotidis, MD27, Olga Kalashnikova, MD28*, Federica Frezzato, PhD29*, Monica Facco, MS29*, Valeria Ruocco, MD29*, Alessia Buratin, PhD12*, Silvia Orsi12*, Alessandro Cellini, MD29*, Francesco Angotzi29*, Chiara Adele Cavarretta, MD29*, Ivan Zatta, MD29*, Andrea Serafin, MD29*, Robin Foa30*, Barbara F. Eichhorst, MD31, Antonio Cuneo, MD32*, Kostas Stamatopoulos33*, Paolo Ghia, MD, PhD34, Stefania Bortoluzzi, PhD35* and Livio Trentin29

1Hematology unit, Department of Medicine, University of Padova, Padova, Italy
2Computational Genomics Group, Department of Molecular Medicine, University of Padova, Padova, ITA
3Department I of Internal Medicine, University of Cologne, Cologne, Germany
4The Ohio State University Comprehensive Cancer Center, Columbus, OH
5Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
6Division of Hematology, The Ohio State University, Columbus, OH
7MLL Munich Leukemia Laboratory, Inning am Ammersee, Germany
8Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic
9Division of Haematology, University Hospitals Dorset, Bournemouth, United Kingdom
10Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, United Kingdom
11Hôpital Pitié-Salpêtrière, Service d'Hématologie, Paris, France
12Computational Genomics Group, Department of Molecular Medicine, University of Padua, Padova, Italy
13Hematology Section, St. Anna University Hospital, Ferrara, Italy
14Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
15Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France
16Servicio de Genética. Hospital Universitario de Navarra, PAMPLONA, Spain
17Servicio de Hematología y Oncología Médica, Hospital Clinico Universitario de Valencia, Valencia, Spain
18Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
19Laboratori de Citogenètica, Servei de Patologia, Hospital del Mar, GRETNHE, IMIM, Barcelona, Spain
20Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy
21Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
22Strategic Research program on CLL, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
23Institute of Applied Biosciences, Centre For Research and Technology Hellas,, Thessaloniki, Greece
24Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany
25Academic Medical Center, Amsterdam Zuidoost, NH, Netherlands
26Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain
27First Department of Propedeutics,University of Athens, Athens, Greece
28Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russian Federation
29Hematology Unit, Department of Medicine, University of Padova, Padova, Italy
30Hematology, University Sapienza and Hospital Umberto I, Rome, Italy
31University of Cologne, Cologne, Germany
32Division of Hematology, University of Ferrara, Ferrara, Ferrara, Italy
33Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
34Universita' Vita-Salute San Raffaele C.F. 97187560152, Milano, MI, Italy
35Computational Genomics Group, Department of Molecular Medicine, University of Padua,, Padova, Italy

Paul J. Hampel, MD1, Kari G. Rabe, MS2*, Yucai Wang, MD, PhD3, Saad S. Kenderian, MD3, Wei Ding, MD, PhD3, Eli Muchtar, MD1, Jose F. Leis, MD, PhD4, Amber Koehler, PA-C5*, Mazie Tsang, MD6, Ricardo Parrondo, MD7, Rachel Bubik, PharmD1*, Susan Marie Schwager1*, Curtis A. Hanson, MD8*, Esteban Braggio, PhD9, Susan L. Slager, PhD10, Min Shi, MD, PhD1*, Daniel L. Van Dyke, PhD1, Timothy G. Call, MD3, Neil E. Kay, MD3,11 and Sameer A. Parikh, MD12

1Mayo Clinic, Rochester, MN
2Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, AZ
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester
6Mayo Clinic, Phoenix, AZ
7Mayo Clinic, Jacksonville, FL
8Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
9Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
10Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
11Department of Immunology, Mayo Clinic, Rochester, MN
12Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

Ahmad Alhuraiji1, Ayman Alhejazi, MD2*, Mohamed Samra3*, Bhausaheb Bagal, MD, DM4*, Miguel Arturo Pavlovsky, MD5, Macarena Roa6*, Shang-Ju Wu7*, Efreen H Montano Figueroa, MD8*, Veena Selvaratnam, MBBS, FRCPath9*, Chee-Yen Lin, MD10*, Pushpalata K11*, Akemi Ishikawa12* and Francisco Gonzalez Hernandez13*

1Kuwait Cancer Centre, Shuwaikh, KWT
2College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
3National Cancer Institute, Cairo University, Cairo, EGY
4Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
5FUNDALEU, Buenos Aires, Argentina
6Hospital Del Salvador, Santiago de Chile, Chile, Buenos Aires, ARG
7National Taiwan University Hospital, Taiwan, Taipei, TWN
8Hospital General de México, Ciudad de México, México, Ciudad de México, Mexico
9Ampang Hospital, Ampang, Malaysia
10National University Hospital (Singapore) Pte Ltd, Singapore, Singapore, Singapore
11International Study Manager/International Evidence Generation Oncology, AstraZeneca Pharma India, India, India
12Pan-International CREEK Study Project Lead/Hematology Medical Manager, AstraZeneca Mexicoakemi, Mexico, Mexico
13International Medical Director, Hematology & Genitourinary Cancer, AstraZeneca, Switzlerland, Switzerland

John N. Allan, MD1, Tao Ran, PhD2*, Zhijie Ding, PhD3*, Jinghua He, PhD, MPH2*, Alex Bokun, PharmD3*, Zaina P Qureshi, PhD, MS, MPH3* and Susan M. O'Brien4

1Weill Cornell Medicine, Long Island City, NY
2Janssen Scientific Affairs, LLC, Titusville, NJ
3Janssen Scientific Affairs, LLC, Horsham, PA
4Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA

Mazyar Shadman, MD, MPH1, Ian W. Flinn, MD, PhD2, Edwin C. Kingsley, MD3*, Benjamin B. Freeman, MD4, Moshe Levy5*, Charles M. Farber, MD, PhD6*, James D'Olimpio, MD7*, Jennifer L. Cultrera, MD8, Ben Zhang, MD9*, Rocco J. Crescenzo, DO10*, Adam Idoine, PhD10*, Xiaoping Zhang, MD10*, Kunthel By, PhD10* and Jeff P. Sharman, MD11

1Fred Hutchinson Cancer Center, Seattle, WA
2Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
3Comprehensive Cancer Centers of Nevada, Las Vegas, NV
4Summit Medical Group, Florham Park, NJ
5Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
6Morristown Medical Center, Atlantic Hematology Oncology, Morristown, NJ
7North Shore University Hospital, Manhasset, NY
8Florida Cancer Specialists & Research Institute, Leesburg, FL
9Minnesota Oncology Clinic, Burnsville, MN
10BeiGene USA, Inc, San Mateo, CA
11Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR

Jacob Soumerai1, Thais Gift2*, Zaid Yousif2,3*, Raj Desai, PhD4*, Lynn Huynh, DrPH, MBA, MPH4*, Gregory Belsky5*, Mei Sheng Duh, RPh, MPH, ScD4 and Marie Sanchirico2*

1Massachusetts General Hospital Cancer Center: Hematology Oncology, Boston, MA
2Takeda Pharmaceuticals USA, Inc., Lexington, MA
3University of California San Diego, La Jolla, CA
4Analysis Group, Inc., Boston, MA
5Mass General Brigham, Research Information Science & Computing, Somerville, MA

Riccardo Bomben1*, Antonella Zucchetto, PhD2*, Roberta Laureana3*, Annalisa Chiarenza, MD4*, Jacopo Olivieri5*, Erika Tissino, PhD6*, Francesca Rossi7*, Filippo Vit, PhD8*, Tamara Bittolo1*, Robel Papotti9*, Federico Pozzo, MSc9*, Annalisa Gaglio9*, Massimo Degan9*, Jerry Polesel10*, Roberto Marasca, MD11, Gianluigi Reda, MD12*, Andrea Visentin, MD, PhD13*, Riccardo Moia, MD14*, Idanna Innocenti, PhD15*, Candida Vitale, MD, PhD16*, Roberta Murru, MD17*, Marzia Varettoni18*, Agostino Tafuri, MD19, Francesco Zaja, MD20*, Massimiliano Postorino21*, Enrica Antonia Martino, MD22,23*, Adalgisa Condolucci24*, Davide Rossi25, Antonio Cuneo, MD26*, Francesco Di Raimondo, MD27, Paolo Sportoletti, MD28*, Ilaria Del Giudice29*, Robin Foa30*, Francesca Romana Mauro31*, Marta Coscia, MD, PhD32*, Luca Laurenti, MD33*, Gianluca Gaidano, MD, PhD34,35, Livio Trentin36, Maria Ilaria Del Principe, MD37*, Massimo Gentile, MD22* and Valter Gattei, MD38

1CRO Aviano National Cancer Institute,Clinical and Experimental Onco-Hematology Unit, Aviano, Italy
2Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
3Division of Haematology, University of Tor Vergata, Rome, Roma, ITA
4Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Catania, Italy
5Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
6Clinical and Experimental Onco-Hematology Unit, Centro Di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
7Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), ITA
8Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy, ITA
9Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
10Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
11Hematology Unit, Department of Oncology and Hematology, Azienda-Ospedaliero Universitaria (AOU) of Modena, Policlinico, Modena, Modena, Italy
12Division of Ematology, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico di Milano, Milano, Milano, Italy
13Hematology unit, Department of Medicine, University of Padova, Padova, Italy
14Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Novara, Italy
15Fondazione Universitaria Policlinico A Gemelli di Roma, Roma, Roma, Italy
16A.O.U. Città della Salute e della Scienza di Torino, Torino, Torino, Italy
17Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS G. Brotzu, Cagliari, CAGLIARI, Italy
18Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
19Department of Clinical and Molecular Medicine and Hematology, Sant'Andrea - University Hospital - Sapienza, University of Rome, Rome, Italy
20DSM, University of Trieste, Trieste, Italy
21Division of Haematology, University of Tor Vergata, Rome, Roma, Italy
22Department of Onco-Hematology, Hematology Unit AO of Cosenza, Cosenza, Italy
23Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy
24Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Bellinzona, Switzerland
25Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
26Division of Hematology, University of Ferrara, Ferrara, Ferrara, Italy
27Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, ITA
28Centro di Ricerca Emato-Oncologica (CREO), Dipartimento di Medicina e Chirurgia, University of Perugia, Perugia, Italy
29Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome, Rome, Italy
30Hematology, University Sapienza and Hospital Umberto I, Rome, Italy
31Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
32A.O.U. Città della Salute e della Scienza di Torino, Torino, Torino, To, ITA
33Division of Hematology, Fondazione Universitaria Policlinico A Gemelli di Roma, Rome, Italy
34SCDU Ematologia, AOU Maggiore della Carità, Novara, ITA
35Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Novara, ITA
36Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
37Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
38Centro Di Riferimento Oncologico, Aviano, Italy

Enrica Antonia Martino, MD1*, Francesca Romana Mauro2*, Gianluigi Reda, MD3*, Luca Laurenti, MD4*, Andrea Visentin, MD, PhD5*, Annamaria Frustaci6*, Ernesto Vigna, MD7*, Sara Pepe, MD, PhD8*, Gioacchino Catania, MD9*, Giacomo Loseto, MD10*, Roberta Murru, MD11*, Annalisa Chiarenza, MD12*, Paolo Sportoletti, MD13*, Maria Ilaria Del Principe, MD14*, Marta Coscia, MD, PhD15*, Sara Galimberti16*, Alessandra Tedeschi17*, Davide Rossi18,19, Livio Trentin20, Fortunato Morabito21*, Valter Gattei, MD22 and Massimo Gentile, MD23*

1UOC Ematologia Cosenza, Cosenza, Italy
2Department of Translational and Precision Medicine, Hematology unit, 'Sapienza' University, Roma, Italy
3Hematology Department, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
4S. Ematologia, Dipartimento Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
5Hematology unit, Department of Medicine, University of Padova, Padova, Italy
6Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
7U.O. Di Ematologia, Ospedale L'Annunziata, Cosenza, ITA
8Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
9Hematology and Marrow Transplant,, A.O. SS Antonio e Biagio e Cesare Arrigo, Alessandria, Alessandria, ITA
10IRCCS Istituto Tumori “Giovanni Paolo II”, Hematology Unit, Bari, Italy
11Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy
12Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Catania, Italy
13Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy
14Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
15A.O.U. Città della Salute e della Scienza di Torino, Torino, Torino, To, ITA
16Ematologia di Pisa, Pisa, ITA
17Niguarda Ca' Granda Hospital, Milano, ITA
18Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
19Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
20Hematology Unit, Department of Medicine, University of Padova, Padova, Italy
21Biothecnology Research Unit, AO of Cosenza, Cosenza, ITA
22Centro Di Riferimento Oncologico, Aviano, Italy
23Haematology, Azienda Ospedaliera di Cosenza, Cosenza, Italy, Cosenza, Italy

Francesco Autore1*, Andrea Visentin, MD, PhD2*, Marina Deodato, MD3*, Candida Vitale, MD, PhD4*, Eugenio Galli5*, Alberto Fresa, MD1*, RITA Fazzi6*, Alessandro Sanna, MD7*, Jacopo Olivieri8*, Ilaria Scortechini9*, Maria Ilaria Del Principe, MD10*, Paolo Sportoletti, MD11*, Luana Schiattone12*, Nilla Maschio13*, Davide Facchinelli14*, Marta Coscia, MD, PhD15*, Alessandra Tedeschi16*, Livio Trentin17, Idanna Innocenti, PhD18*, Anna Candoni, Professor, MD19*, Alessandro Busca20*, Livio Pagano, MD21* and Luca Laurenti, MD22*

1Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
2Hematology unit, Department of Medicine, University of Padova, Padova, Italy
3Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
4A.O.U. Città della Salute e della Scienza di Torino, Torino, Torino, Italy
5Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
6Azienda Ospedaliera Universitaria Pisana, PIsa, Italy
7Hematology, AOU Careggi, Florence, Italy
8Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
9Azienda ospedaliero Universitaria delle Marche, Ancona, Italy
10Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
11Centro di Ricerca Emato-Oncologica (CREO), Dipartimento di Medicina e Chirurgia, University of Perugia, Perugia, Italy
12UOSD Centro Diagnosi e Terapia dei Linfomi, Presidio Ospedaliero Santo Spirito, Pescara, Italy
13Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy
14Ospedale San Bortolo, Vicenza, Italy
15A.O.U. Città della Salute e della Scienza di Torino, Torino, Torino, To, ITA
16ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
17Hematology Unit, Department of Medicine, University of Padova, Padova, Italy
18Fondazione Universitaria Policlinico A Gemelli di Roma, Roma, Roma, Italy
19Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università di Modena e Reggio Emilia, Modena, Italy
20S.S.C.V.D Trapianto di Cellule Staminali, A.O.U Citta della Salute e della Scienza di Torino – Torino, Italy, Torino, Italy
21Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy
22Division of Hematology, Fondazione Universitaria Policlinico A Gemelli di Roma, Rome, Italy

Samuel Kosydar, MD1*, Kari G. Rabe, MS2*, Yucai Wang, MD, PhD3, Saad S. Kenderian, MD1,3, Wei Ding, MD, PhD4, Eli Muchtar, MD5, Jose F. Leis, MD, PhD6, Amber Koehler, PA-C7*, Mazie Tsang, MD8, Ricardo Parrondo, MD9, Talal Hilal, MD8, Rachel Bubik, PharmD1*, Susan Marie Schwager1*, Curtis A. Hanson, MD10*, Esteban Braggio, PhD11, Susan L. Slager, PhD2, Min Shi, MD, PhD1*, Daniel L. Van Dyke, PhD1, Timothy G. Call, MD3, Neil E. Kay, MD1,3, Sameer A. Parikh, MD12 and Paul J Hampel, MD1

1Mayo Clinic, Rochester, MN
2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic-Rochester, Rochester, MN
5Mayo Clinic, Rochester, Minnesota, Rochester, MN
6Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, AZ
7Division of Hematology, Department of Medicine, Mayo Clinic, Rochester
8Mayo Clinic, Phoenix, AZ
9Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
10Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
11Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
12Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

John N. Allan, MD1, Daniel Helbig2, Erin Mulvey2, Sarah Nazir2*, Sandra Stewart2*, Melissa L. Lapinta2*, Sarah C. Rutherford, MD2, Jia Ruan, MD, PhD3, John P. Leonard4, Peter Martin, MD2 and Richard R. Furman2

1Weill Cornell Medicine, Long Island City, NY
2Weill Cornell Medicine, New York
3Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
4Weill Cornell Medicine, New York, NY

Boyu Hu, MD1, Adam S Kittai, MD2, Kenneth Boucher, PhD1*, Tony Pomicter, MS3* and Deborah M. Stephens, DO1

1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
2Division of Hematology, The Ohio State University, Columbus, OH
3The University of Utah, Salt Lake City, UT

David Lavie1*, Muhit Ozcan, MD2, Arvind Chaudhry, MD, PhD3*, Xuan Zhou4*, Ima Paydar4*, Mohammed Z.H. Farooqui, DO4 and Paolo Ghia, MD, PhD5

1Hadassah Medical Center, Jerusalem, Israel
2Hematology Department, Ankara University School of Medicine, Ankara, Turkey
3Summit Cancer Centers, Spokane, WA
4Merck & Co., Inc., Rahway, NJ
5Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy

Nitin Jain, MD1, James D'Olimpio, MD2*, Andew gillis-Smith, MD3*, Seung Tae Lee, MD4, Nirav N. Shah, MD5, Javier Pinilla-Ibarz, MD, PhD6, Catherine C. Coombs, MD7, Jacqueline C. Barrientos, MD8, Shuo Ma, MD, PhD9, Masaaki Sawa, PhD10*, Kyoko Miyamoto11*, Akinori Arimura, PhD11*, Varsha Gandhi, PhD12 and William G. Wierda, MD, PhD13

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Clinical Research Alliance, Westbury, NY
3Hematology/Oncology, University of Massachusetts, Worcester, MA
4Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD
5Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
6H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
7University of California, Irvine, Irvine, CA
8Mount Sinai Medical Center, Miami Beach, FL
9Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
10Carna Biosciences, Inc., Kobe, Japan
11CarnaBio USA, Inc., South San Francisco, CA
12Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
13The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH